StockData

Escalon Medical Corp (ESMC) stock analysis

ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026Score 10/30
$0.18+0.01 (+7.65%)

Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth1Performance4Health5Dividend0

Mixed10 of 30 checks passed

Escalon Medical passes 10 of the 30 checks behind our score; 15 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
1/6
Past performance
4/6
Financial health
5/6
Dividend
0/6

What stands out

  • Return on equity over 15%

    Return on equity was 102% over the last twelve months and averaged 25.9% over five years.

  • No debt

    Escalon Medical has no borrowings on its latest balance sheet.

  • EPS growing 10%+ a year

    Diluted EPS grew 108% a year over the last three fiscal years.

  • Interest well covered

    Operating income covers interest expense 6.1 times.

What to watch

  • Return on capital under 10%

    Return on invested capital was 1.7%, below the 10% that usually covers the cost of capital.

  • Revenue growing under 10% a year

    Revenue grew 1.5% a year over the last three fiscal years, short of the 10% we look for.

  • Growing slower than the industry

    Revenue grew 5.7% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

  • Gross margin slipping

    Gross margin was 43.7% over the last twelve months, against 45.7% a year earlier.

Valuation0/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B against the industry

    Needs positive book value.

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth1/6

  • Revenue growing under 10% a year

    Revenue grew 1.5% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 108% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew 5.7% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin slipping

    Gross margin was 43.7% over the last twelve months, against 45.7% a year earlier.

Past performance4/6

  • Return on equity over 15%

    Return on equity was 102% over the last twelve months and averaged 25.9% over five years.

  • Return on capital under 10%

    Return on invested capital was 1.7%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Escalon Medical's return on equity of 102% is above the Surgical, Medical, and Dental Instruments and Supplies median of -31.3%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was 31.5% over the last twelve months, against a 5-year average of 7.1%.

  • Net margin above the industry

    Escalon Medical's net margin of 31.5% is above the Surgical, Medical, and Dental Instruments and Supplies median of -14.1%.

Financial health5/6

  • No debt

    Escalon Medical has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    Operating income covers interest expense 6.1 times.

  • Short-term assets cover short-term debts

    Current assets are 2.94 times current liabilities.

  • Bankruptcy risk (Altman Z)

    Needs market value, working capital and retained earnings.

Dividend0/6

  • No dividend

    Escalon Medical has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for Escalon Medical. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 6.7
  • Surgical, Medical, and Dental Instruments and Supplies median 27.7

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Margins

Share of revenue, fiscal years 2012 to 2026

Gross margin

43.7%+1.5 pts over 5 years

Operating margin

0.4%+0.7 pts over 5 years

Net margin

31.5%+32.0 pts over 5 years

See a number that looks wrong?